Matrix Pharmacorp Private Limited
Form 483 issued October 19, 2018 · Hyderabad, India
- Inspection
- Oct 15 – Oct 19, 2018
- Observations
- 1
- Pages
- 1
- FEI number
- 3004713397
In short: On October 19, 2018, FDA issued a Form 483 with 1 observation to Matrix Pharmacorp Private Limited in Hyderabad, Telangana (FEI 3004713397) after an inspection that ran Oct 15 – Oct 19, 2018. Most observations concern materials; the most-cited regulation is 21 CFR 211.142 (warehousing procedures).
At a glance
1 of 1 observations on this 483 concern materials.
Most cited: 21 CFR 211.142 (1×)
What FDA observed
Preview: the opening words of each observationDashed: section inferred by FDA Intel and checked against the regulation text
- 01
Raw materials and finished products are not stored under appropriate conditions of temperature so that their…
This inspection in context
Questions about this 483
What did FDA find at Matrix Pharmacorp Private Limited?
FDA listed 1 observation on this Form 483, mostly about materials. The most-cited regulation is 21 CFR 211.142 (warehousing procedures). The opening words of each observation are shown on this page.
When was Matrix Pharmacorp Private Limited inspected by FDA?
The inspection ran Oct 15 – Oct 19, 2018, and the Form 483 is dated October 19, 2018.
How do I get the full Form 483 for Matrix Pharmacorp Private Limited?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.